how much more effective is tirzepatide than semaglutide vs Compared Troubling Findings in Study of

Clinical data show that nausea and vomiting are most common during dose escalation and tend to taper off once you reach a stable dose

Share your thoughts and join the conversation in the comments

Challenges of Stopping GLP-1 Treatment Some individuals may wonder how long they need to continue GLP-1 treatments to achieve lasting benefits

It has been approved by the FDA for weight management in adults with obesity or overweight with at least one weight-related condition

This dual-action effect may help some patients lose weight faster or tolerate the medication better but the best option depends on your body, goals, and how you respond